Physician

Russell Scott Akin, M.D.

According to 2025 Medicare claims, Russell Akin, M.D. (NPI: 1346432440) practices dermatology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is AKIN CHANDLER MD PLLC (NPI: 1811203524; TIN: 270443227) and primary practice location at 79707-5124.

Akin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,148 traditional Medicare patients, billed 9,137 HCPCS/CPT codes, and received $629,910 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 994 prescription claims across 436 beneficiaries totaling $162,098 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 53 records totaling $1,191. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $46,383 to $162,098. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	718	4,974	$456,487
2016	777	3,549	$360,645
2017	671	4,202	$521,346
2018	743	4,438	$505,837
2019	742	6,094	$510,847
2020	725	6,748	$537,885
2021	869	7,159	$560,331
2022	946	8,700	$575,970
2023	1,140	10,032	$563,092
2024	1,148	9,137	$629,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	480	$46,383
2016	220	390	$28,012
2017	74	97	$1,656
2018	184	298	$31,074
2019	325	720	$39,306
2020	328	816	$59,273
2021	398	927	$123,746
2022	386	823	$85,670
2023	428	903	$63,281
2024	436	994	$162,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	263	358	$487
11102	Biopsy of related skin growth, first growth	378	504	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	792	1,139	$59
17000	Destruction of precancer skin growth, 1 growth	511	720	$37
17003	Destruction of precancer skin growth, 2-14 growths	412	2,808	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	100	2,659	$3,287
Triamcinolone Acetonide	Triamcinolone Acetonide	147	4,396	$2,242
Ketoconazole	Ketoconazole	125	3,531	$2,110
Metronidazole	Metronidazole	19	507	$1,436
Fluorouracil	Fluorouracil	19	502	$1,191

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,191	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Russell Scott Akin, M.D.?

Tedicare shows public-source Medicare data for Russell Scott Akin, M.D. (NPI 1346432440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Russell Scott Akin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Russell Scott Akin, M.D.?

Russell Scott Akin, M.D. is linked to AKIN CHANDLER MD PLLC (billing NPI 1811203524) in the available physician profile data.

Does Russell Scott Akin, M.D. have Open Payments data?

Russell Scott Akin, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.